Gastricsin (Recombinant)
- Expression system
- HEK293
- Cat. #
- REC-Gastricsin
In stock
- SKU
- REC-Gastricsin
Target Overview
Gastricsin (gene: PGC; UniProt P20142) is a secreted aspartic endopeptidase belonging to the pepsin family (EC 3.4.23.3), encoded by the PGC gene in humans. The full-length precursor spans 388 amino acids and is synthesised as an inactive zymogen (pepsinogen C) that undergoes autocatalytic activation under acidic conditions to yield the mature enzyme. Mature gastricsin hydrolyzes a broad range of protein substrates and is the predominant pepsin-type enzyme in gastric fluid under neutral-to-slightly-acidic conditions, distinguishing it from pepsin A (PGA) in both substrate preference and pH optimum. This recombinant form is produced in HEK293 mammalian cells, which supports appropriate disulfide bond formation and glycosylation patterns characteristic of the native human protein — features that can be critical when using the protein as a substrate validation control or an immunogen/epitope standard. The HEK293 expression system yields a soluble, secreted product amenable to direct use in enzymatic and binding assays without refolding steps. Researchers employ this recombinant in several in vitro contexts: measuring proteolytic activity against synthetic or protein substrates, determining IC50 values for candidate aspartic protease inhibitors, and serving as a well-defined positive control antigen in Western blot and IHC validation experiments. For antibody validation workflows, this recombinant pairs directly with the Triple Point Biologics matched Gastricsin antibody (SKU: RP-Gastricsin) — a convenient pairing for confirming band identity, setting exposure standards, and benchmarking immunoreactivity across tissue lysates. The defined human sequence origin (UniProt P20142) and mammalian expression context make this reagent a reproducible reference standard across laboratories.
Background
Applications
- Aspartic protease activity assay using fluorogenic or chromogenic peptide substrates at pH 3.0–4.5
- Inhibitor IC50 determination — including pepstatin A benchmarking and novel aspartic protease inhibitor screening
- Zymogen-to-active-enzyme conversion kinetics study under defined acidic conditions
- Antibody validation positive control for Western blot — pairs with Triple Point Biologics RP-Gastricsin antibody
- IHC antibody validation: recombinant used as titration standard to confirm immunoreactivity of RP-Gastricsin
- Substrate specificity profiling by mass spectrometry-based cleavage site mapping
- Protein–protein interaction studies with candidate aspartic protease binding partners or inhibitory proteins
- ELISA standard curve antigen for quantification of gastricsin in gastric fluid or serum research samples
References
- Luo Y et al. Erchen Decoction Induces Browning Tendency in White Adipose Tissue of Obese Rats via the SP1/SREBP/UCP1 Signaling Pathway. Endocr Metab Immune Disord Drug Targets. 2026. doi:10.2174/0118715303415055251209122646. PMID: 42337893.
- Li L et al. AMPK/SIRT1 signaling pathway activation acts on PGC-1α/PPARγ to alleviate sepsis-acquired weakness. Cell Death Discov. 2026. doi:10.1038/s41420-026-03212-w. PMID: 42337228.
- Tang YJ et al. α7nAChR agonist GTS-21 ameliorates sepsis-induced acute kidney injury via MEF2/PGC-1α/HO-1 axis in mice. Clin Transl Med. 2026. doi:10.1002/ctm2.70726. PMID: 42333777.
- Enoki T et al. Effects of Ladder-Climbing Resistance Training on Pyruvate Dehydrogenase Activation in Fast-Twitch Flexor Hallucis Longus Muscles of Rats. Med Sci Sports Exerc. 2026. doi:10.1249/MSS.0000000000004051. PMID: 42330072.
- Darwish WS et al. Carob pod aqueous extract potentiates cisplatin efficacy and reduces toxicity in experimental hepatocellular carcinoma via mitochondrial and inflammatory pathway modulation. Bioresour Bioprocess. 2026. doi:10.1186/s40643-026-01029-0. PMID: 42329491.
Additional Specifications
| Storage Buffer | 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol |
|---|---|
| Endotoxin Level | <0.1 EU/µg by LAL |
| Purity (%) | >90% by SDS-PAGE |
| Expression System | HEK293 |
| Subcellular Localization | Subcellular localization not yet annotated |
Frequently Asked Questions
What molecular weight band should I expect for recombinant Gastricsin on SDS-PAGE or Western blot?
Under denaturing SDS-PAGE conditions, recombinant Gastricsin runs at approximately 42–44 kDa, reflecting the mature processed form produced in HEK293 cells. The full-length zymogen precursor (pepsinogen C) is 388 amino acids with a predicted unglycosylated MW of ~42.8 kDa, but HEK293-derived glycosylation typically shifts the apparent MW slightly upward. If you observe a ~44–46 kDa band under your gel conditions, that is expected. The signal should collapse to the unglycosylated backbone (~42–43 kDa) after PNGase F treatment, which is a useful confirmation of correct identity.
Is the recombinant Gastricsin supplied as the zymogen (pepsinogen C) or the activated mature enzyme?
The product is supplied as the active mature enzyme form, not the full-length zymogen. Autocatalytic removal of the prosegment occurs under acidic conditions during processing; our HEK293-expressed construct is designed to yield the secreted, activated protease. This matters for activity assays: you do not need an acid-activation step before use. If your experiment specifically requires the inactive zymogen to study activation kinetics, note that this recombinant is not appropriate for that application without re-engineering the construct.
What substrates and pH conditions work best for a Gastricsin (EC 3.4.23.3) activity assay?
Gastricsin is most active in the pH 3.0–4.0 range, with a notably higher pH optimum than pepsin A — a key distinguishing feature. For fluorogenic activity assays, a FRET-based peptide substrate such as MoCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2 or a hemoglobin cleavage assay at pH 3.5 in 50 mM sodium acetate buffer are established options in the literature. Avoid assay buffers above pH 5.5, as catalytic activity drops sharply. The storage buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol) keeps the enzyme stable but should be diluted into your acidic assay buffer immediately before use.
What starting concentration should I use for a Gastricsin enzymatic activity assay?
A reasonable starting point for fluorogenic or hemoglobin-digestion assays is 10–50 nM recombinant Gastricsin in your acidic assay buffer (pH 3.0–4.0, 50 mM sodium acetate). At 10 nM, you should see robust signal with most FRET peptide substrates at 100 µM substrate concentration. Titrate enzyme concentration to confirm linearity before comparing inhibitor IC50 values across experiments. Because the protein is active as supplied, avoid pre-warming the enzyme above room temperature during setup — brief incubation on ice prior to adding substrate helps minimize autolysis at acidic pH.
Can I use Gastricsin (Recombinant) as a positive control for Western blot with the matched rabbit polyclonal antibody?
Yes — this is one of the primary intended applications. The matched antibody, RP-Gastricsin (see /anti-gastricsin-rabbit-polyclonal-antibody), is raised from the same lab and has been validated for Western blot against this recombinant. Load 20–50 ng of recombinant Gastricsin per lane alongside your lysate samples. You should detect a clean band at ~42–44 kDa. This gives you a defined positive control that confirms antibody performance and allows you to identify the correct band in complex gastric mucosal or cancer cell line lysates where endogenous Gastricsin expression can vary widely.
How much recombinant Gastricsin should I load as a Western blot positive control, and at what antibody dilution?
Load 20–50 ng per lane for a clean, non-saturating signal. Using RP-Gastricsin at a primary antibody dilution of 1:1,000–1:2,000 (in 5% non-fat milk or BSA in TBST) typically yields a strong band at 42–44 kDa with short ECL exposure times (30–120 seconds). If background is high in your lysate lanes, reduce the recombinant control to 10 ng — the antibody is sensitive enough to detect this amount. Always run the recombinant in a lane adjacent to your experimental samples so band migration can be directly compared on the same gel.
How should I store and handle recombinant Gastricsin to maintain enzymatic activity long-term?
Store at -20°C in single-use aliquots to avoid repeated freeze-thaw cycles, which progressively denature the active enzyme. The supplied buffer — 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol — stabilizes the protein during frozen storage. On the bench, keep aliquots on ice and use within 2–4 hours of thawing. Do not store thawed protein at 4°C beyond 24–48 hours. Purity is >90–95% by SDS-PAGE and endotoxin is <0.1 EU/µg by LAL, so no additional cleanup steps are needed before most cell-based or biochemical experiments.
How does recombinant Gastricsin differ from pepsin A (PGA), and does that matter for my inhibitor profiling experiment?
Gastricsin (pepsinogen C / PGC) and pepsin A (PGA) are related but distinct aspartic proteases with different pH optima and substrate specificities. Gastricsin has a pH optimum around 3.0–4.0 and preferential cleavage at sites flanked by hydrophobic and aromatic residues, but it differs from pepsin A in its relative tolerance for certain P1/P1' combinations. For inhibitor profiling, this distinction is critical: many pepstatin A analogs inhibit both enzymes, but selectivity windows can emerge at pH 3.5 vs. pH 2.0 assay conditions. Running parallel assays with both proteases at equimolar concentrations is the cleanest way to establish selectivity.
Validation imagery coming soon
Western blot validation figures for REC-Gastricsin will be published here as they are produced in-house.
If you would like to see existing validation data for this antibody before publication, request a sample copy.